L. T. Iseri & J. H. French: Magnesium: nature's physiologic calcium blocker. In: American Heart Journal. Band108, Nr.1, Juli 1984, S.188–193, doi:10.1016/0002-8703(84)90572-6, PMID 6375330 (regulations.gov [PDF; abgerufen am 19. August 2024]).
Hartmut Glossmann, David R. Ferry u. a.: Calcium channels: direct identification with radioligand binding studies. In: Trends in Pharmacological Sciences, 3, 1982, S. 431–437, doi:10.1016/0165-6147(82)91221-4.
nih.gov
ncbi.nlm.nih.gov
L. T. Iseri & J. H. French: Magnesium: nature's physiologic calcium blocker. In: American Heart Journal. Band108, Nr.1, Juli 1984, S.188–193, doi:10.1016/0002-8703(84)90572-6, PMID 6375330 (regulations.gov [PDF; abgerufen am 19. August 2024]).
D. R. Ferry, H. Glossmann: Evidence of multiple receptor sites within the putative calcium channel. In: Naunyn Schmiedebergs Arch Pharmacol, 321(1), Oct 1982, S. 80–83. PMID 6292744
C. Gasse, J. Stieber, A. Döring, U. Keil, H. W. Hense: Population trends in antihypertensive drug use: results from the MONICA Augsburg Project 1984 to 1995. In: J Clin Epidemiol, 52(7), Jul 1999, S. 695–703. PMID 10391663.
H. Knopf, H. U. Melchert, A. Bertelsmann: Consumption of calcium antagonists: results of the German national health surveys. In: Pharmacoepidemiol Drug Saf, 9(3), May 2000, S. 221–233. PMID 19025823.
K. A. Al Khaja, R. P. Sequeira: Pharmacoepidemiology of antihypertensive drugs in primary care setting of Bahrain between 1998 and 2000. In: Pharmacoepidemiol Drug Saf, 15(10), Oct 2006, S. 741–748. PMID 16342299.
regulations.gov
downloads.regulations.gov
L. T. Iseri & J. H. French: Magnesium: nature's physiologic calcium blocker. In: American Heart Journal. Band108, Nr.1, Juli 1984, S.188–193, doi:10.1016/0002-8703(84)90572-6, PMID 6375330 (regulations.gov [PDF; abgerufen am 19. August 2024]).
